Europe’s drug regulator has recommended a different injection method and dosage for the monkeypox vaccine to increase the number of available shots as supplies run low and cases rise worldwide.
The European Medicines Agency Emergency Task Force said the Imvanex vaccine from Bavarian Nordic A/S can now be administered intradermally at a lower dose so that more people can be vaccinated.
An intradermal injection occurs between layers of skin, rather than under the skin, and will mean a single vial of the vaccine, also known as Jynneos, can supply five shots instead of just one.
